永泰生物-B根据供股发行1.03亿股供股股份

Core Viewpoint - Yongtai Bio-B (06978) announced a rights issue on November 13, 2025, offering one rights share for every five existing shares held, resulting in the allocation and issuance of 103 million rights shares [1] Group 1 - The company will issue a total of 103 million rights shares as part of the rights offering [1] - The rights issue is structured at a ratio of one share for every five existing shares [1] - The announcement indicates a strategic move to raise capital through the rights issue [1]